- Synvisc One is a better option for knee osteoarthritis (OA) patients who have mild pain not adequately managed by oral painkillers, do not have severe joint degeneration requiring surgery, and want to delay total knee replacement surgery. - Combining Synvisc One with mild painkillers can better manage OA than stronger NSAIDs, which risk stomach ulcers and renal damage with chronic use. Synvisc One also helps maintain joint status quo, unlike oral drugs that do not stop disease progression. - A patient support program for Synvisc One should provide information on OA and the treatment, reminders for medication timing, assistance with costs, and connect patients to local doctors and